TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
34.58
-0.80 (-2.26%)
At close: Apr 28, 2026, 4:00 PM EDT
34.63
+0.05 (0.15%)
After-hours: Apr 28, 2026, 4:59 PM EDT
TG Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 49.8, with a low estimate of 39 and a high estimate of 60. The average target predicts an increase of 44.01% from the current stock price of 34.58.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 2, 2026.
Analyst Ratings
The average analyst rating for TG Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $49 → $46 | Buy | Maintains | $49 → $46 | +33.02% | Feb 2, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $37 → $39 | Hold | Maintains | $37 → $39 | +12.78% | Jan 15, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $46 → $49 | Buy | Maintains | $46 → $49 | +41.70% | Nov 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +73.51% | Oct 6, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $53 → $55 | Strong Buy | Maintains | $53 → $55 | +59.05% | Sep 17, 2025 |
Financial Forecast
Revenue This Year
918.76M
from 616.29M
Increased by 49.08%
Revenue Next Year
1.16B
from 918.76M
Increased by 26.69%
EPS This Year
1.48
from 2.77
Decreased by -46.61%
EPS Next Year
2.28
from 1.48
Increased by 54.48%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 963.9M | 1.3B | ||||||
| Avg | 918.8M | 1.2B | ||||||
| Low | 869.8M | 925.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 56.4% | 41.2% | ||||||
| Avg | 49.1% | 26.7% | ||||||
| Low | 41.1% | 0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.68 | 3.24 | |||
| Avg | 1.48 | 2.28 | |||
| Low | 1.19 | 1.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -39.4% | 119.4% | |||
| Avg | -46.6% | 54.5% | |||
| Low | -57.2% | 16.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.